Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Primary Purpose
Coronary Artery Disease, Chest Pain
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
CCTA ~ BREAST SHIELDS
Sponsored by
About this trial
This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring radiation, cardiac computed tomography, CCTA, breast shielding, Myocardial perfusion scintigraphy, MPS, Invasive coronary angiography, ICA
Eligibility Criteria
Inclusion Criteria:
- Adult male and female adult subjects (age greater than 18 years)
- Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).
Exclusion Criteria:
- Female patients that identify themselves as pregnant or have a positive pregnancy test prior to cardiac imaging.
- History (present or past) of leukemia or lymphoma.
- History of radiation therapy
- X-ray examination or scintigraphy within the last 72 hours.
- History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
No Intervention
No Intervention
Arm Label
CCTA Breast Shields
CCTA No Breast Shields
Observational Arm
Arm Description
Within female subset, randomization to wearing bismuth breast shield.
Within female subset, randomization to wearing no bismuth breast shield (standard of care).
Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.
Outcomes
Primary Outcome Measures
Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging
The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.
Secondary Outcome Measures
Full Information
NCT ID
NCT02617888
First Posted
November 19, 2015
Last Updated
June 12, 2017
Sponsor
Walter Reed National Military Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02617888
Brief Title
Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Official Title
The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Walter Reed National Military Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Purpose
To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells.
To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.
Detailed Description
The primary objective of the study is to analyze blood and hair samples from patients undergoing cardiac imaging to estimate radiation exposure levels as well as their biological effects (i.e. to determine the degree of genotoxicity by measuring the amounts of DNA double-strand breaks).
The secondary objective is to investigate whether the use of in-plane breast shielding in female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Chest Pain
Keywords
radiation, cardiac computed tomography, CCTA, breast shielding, Myocardial perfusion scintigraphy, MPS, Invasive coronary angiography, ICA
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
228 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CCTA Breast Shields
Arm Type
Active Comparator
Arm Description
Within female subset, randomization to wearing bismuth breast shield.
Arm Title
CCTA No Breast Shields
Arm Type
No Intervention
Arm Description
Within female subset, randomization to wearing no bismuth breast shield (standard of care).
Arm Title
Observational Arm
Arm Type
No Intervention
Arm Description
Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.
Intervention Type
Radiation
Intervention Name(s)
CCTA ~ BREAST SHIELDS
Other Intervention Name(s)
BISMUTH BREAST SHIELDS
Intervention Description
Breast shield placement (randomized) among women.
Primary Outcome Measure Information:
Title
Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging
Description
The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.
Time Frame
Change from baseline double strand DNA breaks at 30 minutes post-imaging
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult male and female adult subjects (age greater than 18 years)
Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).
Exclusion Criteria:
Female patients that identify themselves as pregnant or have a positive pregnancy test prior to cardiac imaging.
History (present or past) of leukemia or lymphoma.
History of radiation therapy
X-ray examination or scintigraphy within the last 72 hours.
History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Todd C Villines, MD
Organizational Affiliation
WRNMMC
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
We'll reach out to this number within 24 hrs